News
Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...
Prodigy Chief Medical Officer Dr. Eugene Chung will guide the medical device product development firm's clinical strategy.
The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to ...
Patients with heart failure experience worsening neuropsychological outcomes over six months, according to a study published ...
Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and ...
8d
Medical Device Network on MSNFDA conditionally approves second cohort of Carmat’s artificial heart studyThe design of the study features two successive cohorts ... addressing the shortage of available human grafts for individuals ...
7d
Clinical Trials Arena on MSNDSMB recommends continuation of BioCardia’s cell therapy trial for heart failureAn independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...
Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system ...
An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results